Green River Biotech Co., Ltd.: 2026 Q1 EPS NT$4.15
Green River Biotech reported strong Q1 2026 financial results with a basic EPS of NT$4.15, operating revenue of NT$870 million, and after-tax net profit of NT$427 million, highlighting solid growth in the biotechnology and medical industry.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: May 14, 2026 at 08:00 (1775h 0m after Published)
- 🤖 AI Analyzed: May 14, 2026 at 08:10 (9 min after Collected)
Company Code: 6534
Company Name: Green River Biotech Co., Ltd.
Industry: Biotechnology and Medical Industry
Period: 2026 Q1
Basic Earnings Per Share: NT$4.15
Operating Revenue: NT$870 million
Net Profit After Tax: NT$427 million
Company Name: Green River Biotech Co., Ltd.
Industry: Biotechnology and Medical Industry
Period: 2026 Q1
Basic Earnings Per Share: NT$4.15
Operating Revenue: NT$870 million
Net Profit After Tax: NT$427 million